期刊的影响因子--文章列表

期刊文章列表
Jingyu Xu^1,2，Gang An^1,2，Lugui Qiu^1,2（State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College；Tianjin Institutes of Health Science）.Immunotherapy for multiple myeloma: new chances and hope[J].Cancer Biology ＆ Medicine,2023,第10期 Junfeng Xu^1,2,3,4,5，Wuhu Zhang^1,2,3,4,5，Xin Lou^1,2,3,4,5，Zeng Ye^1,2,3,4,5，Yi Qin^1,2,3,4,5，Jie Chen^2,3，Xiaowu Xu^1,2,3,4,5，Xianjun Yu^1,2,3,4,5，Shunrong Ji^1,2,3,4,5（Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center；Center for Neuroendocrine Tumors, Fudan University Shanghai Cancer Center；Department of Oncology,Shanghai Medical College, Fudan University；Shanghai Pancreatic Cancer Institute；Pancreatic Cancer Institute, Fudan University）.Recent research hotspots in sequencing and the pancreatic neuroendocrine tumor microenvironment[J].Cancer Biology ＆ Medicine,2023,第10期 Tianqing Yan^1,2，Xiaolu Ma^1,2，Lin Guo^1,2，Renquan Lu^1,2（Department of Clinical Laboratory, Fudan University Shanghai Cancer Center；Department of Oncology, Shanghai Medical College, Fudan University）.Targeting endoplasmic reticulum stress signaling in ovarian cancer therapy[J].Cancer Biology ＆ Medicine,2023,第10期 Leilei Yang^1,2，Songya Li²，Liuhui Chen²，Yi Zhang¹（Biotherapy Center, The First Affiliated Hospital of Zhengzhou University；Department of Stomatology, The First Affiliated Hospital of Zhengzhou University）.Emerging roles of plasmacytoid dendritic cell crosstalk in tumor immunity[J].Cancer Biology ＆ Medicine,2023,第10期 Yubei Huang，Zhangyan Lyu，Yu Zhang，Xiaomin Liu，Yacong Zhang，Ya Liu，Chao Sheng，Hongyuan Duan，Zeyu Fan，Chenyang Li，Xiao Lin，Zhuowei Feng，Lu Zheng，Zhaoxiang Ye，Hong Lu，Ying Zhu，Dejun Zhou，Xi Wei，Li Ren，Bin Meng，Fangfang Song，Fengju Song，Kexin Chen，the C-BLAST Group（Department of Cancer Epidemiology and Biostatistics；Department of Radiology；Department of Breast Imaging Diagnosis；Department of Endoscopy；Department of Ultrasound Imaging Diagnosis；Department of Clinical Laboratory；Department of Pathology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer）.Cohort profile: design and methods of the Chinese colorectal,breast, lung, liver, and stomach cancer screening trial(C-BLAST)[J].Cancer Biology ＆ Medicine,2023,第10期 Lei-Jie Dai^1,2，Yu-Wei Li^1,2，Ding Ma^1,2，Zhi-Ming Shao^1,2，Yi-Zhou Jiang^1,2（Department of Breast Surgery, Fudan University Shanghai Cancer Center；Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center）.Next-generation antibody–drug conjugates revolutionize the precise classification and treatment of HER2-expressing breast cancer[J].Cancer Biology ＆ Medicine,2023,第10期 Robin L.Jones¹，Marin Gol?i?²（Sarcoma Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Fulham Road；Clinic for Tumors, Clinical Hospital Center）.Recent advances in the systemic treatment of gastrointestinal stromal tumors[J].Cancer Biology ＆ Medicine,2023,第10期 Qi Zhang¹，Jian Li²，Lin Shen²，Yongsheng Li¹，Xicheng Wang²（Department of Medical Oncology, Chongqing University Cancer Hospital；Department of Gastrointestinal Oncology, Laboratory of Carcinogenesis and Translational Research of the Ministry of Education, Peking University School of Oncology, Beijing Cancer Hospital & Institute）.Opportunities and challenges of immunotherapy for dMMR/MSI-H colorectal cancer[J].Cancer Biology ＆ Medicine,2023,第10期 Zhou Zhu，Hui Tang，Jinrong Ying，Yuejuan Cheng，Xiang Wang，Yingyi Wang，Chunmei Bai（Department of Medical Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College；4+4 Medical Doctor Program, Chinese Academy of Medical Sciences &Peking Union Medical College）.Efficacy and safety of gemcitabine plus S-1 vs.gemcitabine plus nab-paclitaxel in treatment-naïve advanced pancreatic ductal adenocarcinoma[J].Cancer Biology & Medicine,2023,第10期 Changjiang Yang，Long Zhao，Yilin Lin，Shan Wang，Yingjiang Ye，Zhanlong Shen（Department of Gastroenterological Surgery, Laboratory of Surgical Oncology, Key Laboratory of Colorectal Cancer Diagnosis and Treatment Research, Peking University People’s Hospital）.Biomarkers for immune checkpoint inhibitors in colorectal cancer: recent advances and future perspectives[J].Cancer Biology ＆ Medicine,2023,第9期 Mengyuan Yang¹，Ziheng Xu¹，Mi Mi¹，Yuwei Ding¹，Yuefen Pan²，Ying Yuan^1,3,4,5，Weijing Sun⁶，Shanshan Weng^1,3,4,5（Department of Medical Oncology (Key Laboratory of Cancer Prevention and Intervention, Chinese National Ministry of Education, Key Laboratory of Molecular Biology in Medical Sciences, Zhejiang Province, China), The Second Affiliated Hospital, Zhejiang University School of Medicine；Department of Medical Oncology, Huzhou Central Hospital；Zhejiang Provincial Clinical Research Center for Cancer；Cancer Center of Zhejiang University；Binjiang Institute of Zhejiang University；Department of Medical Oncology, The University of Kansas, School of Medicine）.CSCO guidelines for metastatic colorectal cancer:personalized medicine in clinical practice[J].Cancer Biology ＆ Medicine,2023,第9期 Mengyuan Li¹，Minghuan Zhang¹，Qian Ye²，Yunhua Liu³，Wenbin Qian¹（Department of Hematology, the Second Affiliated Hospital, Zhejiang University School of Medicine；Hangzhou Rong-Gu Biotechnology Limited Company；Department of Pathology &Pathophysiology and Department of Surgical Oncology of the Second Affiliated Hospital, Zhejiang University School of Medicine）.Preclinical and clinical trials of oncolytic vaccinia virus in cancer immunotherapy: a comprehensive review[J].Cancer Biology ＆ Medicine,2023,第9期 Xiaohui Wang^1,2，Wei Qiu³，Haoyu Liu¹，Min He²，Wei He¹，Zhan Li²，Zhiqiang Wu⁴，Xiang Xu²，Ping Chen¹（College of Biotechnology, Southwest University；Department of Stem Cell & Regenerative Medicine, State Key Laboratory of Trauma, Burn and Combined Injury, Daping Hospital, Army Medical University；Department of Dermatology, The First Affiliated Hospital of Wenzhou Medical University；Department of Biotherapeutics, The First Medical Center, Chinese PLA General Hospital）.The inducible secreting TLR5 agonist, CBLB502, enhances the anti-tumor activity of CAR133-NK92 cells in colorectal cancer[J].Cancer Biology ＆ Medicine,2023,第9期 Jia Chen^1,2,3,4,5，Jie Shi^4,5，Jian Zheng^4,5，Yunlong Wang^1,2,3,4，Xiangbo Wan^1,2,3,4（Henan Provincial Key Laboratory of Radiation Medicine, The First Affiliated Hospital of Zhengzhou University；Academy of Medical Sciences, Zhengzhou University；Department of Radiation Oncology, The First Affiliated Hospital of Zhengzhou University；Department of Radiation Oncology, The Sixth Affiliated Hospital, Sun Yat-sen University；Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital, Sun Yat-sen University）.Liquid-liquid phase separation in DNA double-strand break repair[J].Cancer Biology ＆ Medicine,2023,第9期 Xiaoying Zhao^1,2，Zhiyu Chen^1,2，Xiaowei Zhang^1,2，Xiaodong Zhu^1,2，Wen Zhang^1,2，Lixin Qiu^1,2，Chenchen Wang^1,2，Mingzhu Huang^1,2，Zhe Zhang^1,2，Wenhua Li^1,2，Lei Yang³，Weijian Guo^1,2（Department of Gastrointestinal Medical Oncology, Fudan University Shanghai Cancer Center；Shanghai Medical College, Fudan University；Department of Medical Oncology, Nantong Tumor Hospital）.Comparing effectiveness and safety of paclitaxel plus raltitrexed vs.paclitaxel alone in second-line palliative chemotherapy for metastatic gastric adenocarcinoma:A randomized phase II clinical trial[J].Cancer Biology & Medicine,2023,第9期 Danqi Fu¹，Jingrui Yan¹，Zhaoyu Zhang¹，Yang Liu²，Xiaoqing Ma¹，Jinsheng Ding¹，Shengyu Yang³，Ran Zhao¹，Antao Chang¹，Chuntao Gao¹，Jing Liu¹，Tiansuo Zhao¹，Xiuchao Wang¹，Chongbiao Huang¹，Song Gao¹，Ying Ma¹，Bo Tang¹，Yukuan Feng¹，Hongwei Wang¹，Jihui Hao¹（Department of Pancreatic Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Centre for Cancer, Key Laboratory of Cancer Prevention and Therapy；Department of General Surgery,Changzheng Hospital, Naval Medical University (Second Military Medical University)；Department of Cellular and Molecular Physiology, Penn State College of Medicine, Hershey）.Nuclear PLD1 combined with NPM1 induces gemcitabine resistance through tumorigenic IL7R in pancreatic adenocarcinoma[J].Cancer Biology & Medicine,2023,第8期 Dongyao Wang^1,2,3,4，Haiming Wei^1,2,3（Department of Hematology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China；Institute of Immunology and the CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Basic Medicine and Medical Center, University of Science and Technology of China；The CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Basic Medicine and Medical Center,University of Science and Technology of China；Blood and Cell Therapy Institute, Anhui Provincial Key Laboratory of Blood Research and Applications, University of Science and Technology of China）.Natural killer cells in tumor immunotherapy[J].Cancer Biology & Medicine,2023,第8期 Jiameng Dan^1,2，Zeling Du^1,2，Jinghong Zhang^1,2，Taiping Chen^3,4（State Key Laboratory of Primate Biomedical Research, Institute of Primate Translational Medicine, Kunming University of Science and Technology；Yunnan Key Laboratory of Primate Biomedical Research；Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center；Programs in Genetics and Epigenetics, The University of Texas MD Anderson Cancer Center UT Health Graduate School of Biomedical Sciences）.The interplay between H3K36 methylation and DNA methylation in cancer[J].Cancer Biology & Medicine,2023,第8期 Bisheng Cheng，Hai Huang（Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University）.Expanding horizons in overcoming therapeutic resistance in castration-resistant prostate cancer：targeting the androgen receptor-regulated tumor immune microenvironment[J].Cancer Biology & Medicine,2023,第8期 Juan Hui^1,2，Mingzhen Zhou²，Guangzhou An^1,3，Hui Zhang^1,4，Yuanyuan Lu²，Xin Wang¹，Xiaodi Zhao²（Department of Gastroenterology, Tangdu Hospital, Air Force Medical University；State Key Laboratory of Cancer Biology and National Clinical Research Center for Digestive Diseases, Xijing Hospital of Digestive Diseases, Air Force Medical University；Department of Radiation Protection Medicine, Ministry of Education Key Laboratory of Hazard Assessment and Control in Special Operational Environment, Faculty of Preventive Medicine, Air Force Medical University；Department of Traditional Chinese Medicine, Tangdu Hospital, Air Force Medical University）.Regulatory role of exosomes in colorectal cancer progression and potential as biomarkers[J].Cancer Biology & Medicine,2023,第8期 Yize Li，Yinmiao Bai，Hongchen Ji，Zhihui Liu，Hongmei Zhang（Department of Clinical Oncology, Xijing Hospital, The Fourth Military Medical University）.New era：prospects for managing cancer of unknown primary[J].Cancer Biology & Medicine,2023,第8期 Qingyu Lin^1,2,3，Jiaqi Zhu^2,4，Ying Hu^1,2,3（School of Life Science and Technology, Harbin Institute of Technology；Zhengzhou Research Institute of Harbin Institute of Technology；Key Laboratory of Science and Engineering for the Multi-modal Prevention and Control of Major Chronic Diseases, Ministry of Industry and Information Technology；School of Astronautics, Harbin Institute of Technology）.Involvement of lncRNAs in the tumor microenvironment：a new property of tumor immunity[J].Cancer Biology & Medicine,2023,第8期 Rafael Rosell^1,2，Anisha Jain³，Jordi Codony-Servat⁴，Eloisa Jantus-Lewintre^5,6，Blake Morrison⁷，Jordi Barretina Ginesta¹，María González-Cao²（Germans Trias i Pujol Research Institute；IOR, Hospital Quiron-Dexeus；Department of Microbiology, JSS Academy of Higher Education & Research；Pangaea Oncology,Hospital Quiron-Dexeus；Department of Biotechnology；Universitat Politècnica de Valencia; Mixed Unit TRIAL (General University Hospital of Valencia Research Foundation and Príncipe Felipe Research Center)；Sumitomo Pharma Oncology, Inc., Cambridge, MA and Lehi）.Biological insights in non-small cell lung cancer[J].Cancer Biology & Medicine,2023,第7期 Tianxing Zhou¹，Xueyang Li^1,2，Jing Liu^1,2，Jihui Hao¹（Department of Pancreatic Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy；Department of Breast Oncoplastic Surgery, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education）.The Hippo/YAP signaling pathway: the driver of cancer metastasis[J].Cancer Biology & Medicine,2023,第7期 Ruixin Yang¹，Yutong Du¹，Wingyan Kwan¹，Ranlin Yan¹，Qimeng Shi¹，Lu Zang¹，Zhenggang Zhu¹，Jianming Zhang²，Chen Li¹，Yingyan Yu¹（Department of General Surgery of Ruijin Hospital, Shanghai Institute of Digestive Surgery, Shanghai Key Laboratory for Gastric Neoplasms, Shanghai Jiaotong University School of Medicine；Institute of Translational Medicine, Zhangjiang Institute for Advanced Study, Shanghai Jiao Tong University）.A quick and reliable image-based AI algorithm for evaluating cellular senescence of gastric organoids[J].Cancer Biology & Medicine,2023,第7期 Zefang Chen¹，Xinyu Cheng¹，Li Yang²，Xiaoming Cheng³，Bo Zhu¹，Haixia Long¹（Institute of Cancer, Xinqiao Hospital, Third Military Medical University；School of Pharmacy and Bioengineering, Chongqing University of Technology；Department of Respiratory Disease,Xinqiao Hospital, Third Military Medical University）.Mechanism and effects of extramedullary hematopoiesis on anti-tumor immunity[J].Cancer Biology & Medicine,2023,第7期 Sicheng Du，Ying Zhang，Jianming Xu²（Department of Graduate Administration, Chinese People’s Liberation Army (PLA) General Hospital；Department of Oncology, The Fifth Medical Center of the PLA General Hospital）.Current progress in cancer treatment by targeting FGFR signaling[J].Cancer Biology & Medicine,2023,第7期首页上一页 1 2 3 4 下一页尾页共有4页，转到页

期刊文章列表